About: Rapid Molecular Panels: What Is in the Best Interest of the Patient? A Review of Patient Outcome Studies for Multiplex Panels Used in Bloodstream, Respiratory, and Neurological Infections

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rapid Molecular Panels: What Is in the Best Interest of the Patient? A Review of Patient Outcome Studies for Multiplex Panels Used in Bloodstream, Respiratory, and Neurological Infections Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Rapid Molecular Panels: What Is in the Best Interest of the Patient? A Review of Patient Outcome Studies for Multiplex Panels Used in Bloodstream, Respiratory, and Neurological Infections
Creator	Sullivan, Kaede Sullivan, V
Source	Elsevier; Medline; PMC
abstract	Abstract In the clinical microbiology laboratory, the focus when choosing new tests is often on performance, turnaround time, and labor needs. This review examines available rapid, multiplexed tests from a different perspective: that of the patient. It considers whether published evidence supports the notion that use of rapid, on-demand tests (as opposed to batched testing) leads to better patient outcomes and whether broad, syndrome-based, multiplexed panels translate into better patient care than narrower monoplex or duplex assays. Finally, we examine how synergy between the clinical microbiology and antimicrobial stewardship programs is necessary to ensure that rapid tests, if implemented, impact the patients they are designed to support.
has issue date	2017-08-15(xsd:dateTime)
bibo:doi	10.1016/j.clinmicnews.2017.08.001
bibo:pmid	32336853
has license	els-covid
sha1sum (hex)	9f2944c9e89c51e2767df89fa841979ec538b0fb
schema:url	https://doi.org/10.1016/j.clinmicnews.2017.08.001
resource representing a document's title	Rapid Molecular Panels: What Is in the Best Interest of the Patient? A Review of Patient Outcome Studies for Multiplex Panels Used in Bloodstream, Respiratory, and Neurological Infections
has PubMed Central identifier	PMC7172105
has PubMed identifier	32336853
schema:publication	Clinical Microbiology Newsletter
resource representing a document's body	covid:9f2944c9e89c51e2767df89fa841979ec538b0fb#body_text
is schema:about of	named entity 'opposed' named entity 'microbiology' named entity 'tests' named entity 'OUTCOMES' named entity 'duplex' named entity 'published' named entity 'rapid' named entity 'Lactococcus' named entity 'Patient' named entity 'Infections' named entity 'Report' named entity 'rapid tests' named entity 'multiplexed' named entity 'patient care' named entity 'Case Report' named entity 'Endocarditis' named entity 'laboratory' named entity 'hospital-acquired' named entity 'Blood Culture' named entity 'infection' named entity 'point-of-care' named entity 'nasopharyngeal' named entity 'clinical complications' named entity 'antimicrobial' named entity 'multiplexed' named entity 'experimental designs' named entity 'bronchoalveolar lavage' named entity 'pathogens' named entity 'S. agalactiae' named entity 'influenza' named entity 'B virus' named entity '2.2' named entity 'antimicrobials' named entity 'clinical medicine' named entity 'viral culture' named entity 'renal toxicity' named entity 'control group' named entity 'acyclovir' named entity 'high-quality' named entity 'adequately powered' named entity 'high-quality evidence' named entity 'time-lapse microscopy' named entity 'clinical outcomes' named entity 'viruses' named entity 'antibiotic' named entity 'respiratory infections' named entity '1.1' named entity 'antimicrobial' named entity 'PCR' named entity 'blinded study' named entity 'influenza virus' named entity 'Chlamydophila pneumoniae' named entity 'antigen' named entity 'Gram-Positive and Gram-Negative' named entity 'encephalitis' named entity 'control group' named entity 'antibiotics' named entity 'Flu' named entity 'blood cultures' named entity 'pediatric' named entity 'PCR' named entity 'therapeutic drug monitoring' named entity 'Durham, NC' named entity 'pediatric' named entity 'empirical treatment' named entity 'IDSA' named entity 'neurological' named entity 'acyclovir' named entity 'negative result' named entity 'L. monocytogenes' named entity 'antimicrobial' named entity 'viruses' named entity 'Bloodstream infections' named entity 'adequately powered' named entity 'bacterial meningitis' named entity 'Bordetella' named entity 'respiratory infections' named entity 'pathogen' named entity 'central nervous' named entity '3, 4'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software